BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33840565)

  • 1. What has the National Cancer Database taught us about oral cavity squamous cell carcinoma?
    Graillon N; Iocca O; Carey RM; Benjamin K; Cannady SB; Hartner L; Newman JG; Rajasekaran K; Brant JA; Shanti RM
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):10-17. PubMed ID: 33840565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Utility and Cost of Routine Staging Exam under Anesthesia for Oral Cavity Squamous Cell Carcinoma.
    Hamdi OA; Dougherty MI; Rasamny JJ; Greyson MA; Christophel JJ; Shonka DC; Fedder KL; Jameson MJ; Garneau JC
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):72-79. PubMed ID: 36513031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base.
    Luryi AL; Chen MM; Mehra S; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):593-8. PubMed ID: 25974757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study.
    Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Kreppel M; Zöller J; Fridman E; Bolzoni VA; Shah JP; Binenbaum Y; Patel SG; Gil Z;
    Cancer; 2013 Dec; 119(24):4242-8. PubMed ID: 24114787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma.
    Gogarty DS; Lennon P; Deady S; Barry O'Sullivan J; McArdle O; Leader M; Sheahan P; O'Neill JP
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):953-960. PubMed ID: 27554664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.
    Nguyen E; McKenzie J; Clarke R; Lou S; Singh T
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1779-1793. PubMed ID: 33744243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do demographics and tumour-related factors affect nodal yield at neck dissection? A retrospective cohort study.
    Lim RS; Evans L; George AP; de Alwis N; Stimpson P; Merriel S; Giddings CE; Billah B; Smith JA; Safdar A; Sigston E
    J Laryngol Otol; 2017 Jan; 131(S1):S36-S40. PubMed ID: 27786150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
    Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
    Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    Warshavsky A; Rosen R; Nard-Carmel N; Abu-Ghanem S; Oestreicher-Kedem Y; Abergel A; Fliss DM; Horowitz G
    JAMA Otolaryngol Head Neck Surg; 2019 Jun; 145(6):542-548. PubMed ID: 31070693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of PET-CT in detecting nodal metastasis in cN0 early stage oral cavity squamous cell carcinoma.
    Zhang H; Seikaly H; Biron VL; Jeffery CC
    Oral Oncol; 2018 May; 80():89-92. PubMed ID: 29706193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis.
    Farhood Z; Simpson M; Ward GM; Walker RJ; Osazuwa-Peters N
    Laryngoscope; 2019 Jun; 129(6):1400-1406. PubMed ID: 30408182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer.
    Cramer JD; Sridharan S; Ferris RL; Duvvuri U; Samant S
    Laryngoscope; 2019 Jan; 129(1):162-169. PubMed ID: 30284248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database.
    Barrett TF; Mazul AL; Stepan KO; Wood CB; Paniello RC; Zevallos JP; Massa S; Jackson RS; Schmitt NC; Zenga J; Kang SY; Pipkorn P; Rich JT; Puram SV
    Oral Oncol; 2021 Jul; 118():105330. PubMed ID: 33991757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinomas of the oral cavity.
    Cernea C; Montenegro F; Castro I; Cordeiro A; Gayotto L; Ferraz A; de Carlucci D
    Am J Surg; 1997 Nov; 174(5):548-51. PubMed ID: 9374235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology protocol increases lymph node yield in neck dissection for oral cavity squamous cell carcinoma.
    Holcomb AJ; Perryman M; Goodwin S; Penn J; Villwock MR; Bur AM; Shnayder Y; Tsue TT; Woodroof J; Kakarala K
    Head Neck; 2020 Oct; 42(10):2872-2879. PubMed ID: 32578921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma.
    Chen JJ; Shah JL; Harris JP; Bui TT; Schaberg K; Kong CS; Kaplan MJ; Divi V; Schoppy D; Le QT; Hara WY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):775-783. PubMed ID: 28602409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.